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Abstract 
 
The investigation of the linkage isomers of biologically essential and kinetically labile metal 
complexes in aqueous solutions poses a challenge, as these microspecies cannot be separately 
studied. Therefore, derivatives are commonly used to initially determine the stability or 
spectral characteristics of at least one of the isomers. Here we directly detect the isomers, 
describe the metal ion coordination sphere, speciation and thermodynamic parameters by 
synergistic application of temperature dependent EPR and CD spectroscopic measurements in 
copper(II)–dipeptide systems including His-Gly and His-Ala ligands. The ∆H = ~ (–
22 4) kJ/mol value of the standard enthalpy change corresponding to the peptide-type to 
histamine-type isomerisation equilibrium of the [CuL]
+
 complex was corroborated by several 
techniques. The preferential coordination of the side-chains was observed at lower 
temperatures, whereas, metal-binding of the backbone atoms became favourable upon 
increasing temperature. This study exemplifies the necessity of using temperature dependent 
multiple methodology for reliable description of similar systems for upstream applications. 
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Introduction 
 
As the understanding of basic biological and chemical processes, also the design of a new 
drug or a catalyst demands the characterization of isomeric species. Metal complexes exhibit 
structural (e.g. linkage, coordination isomers, or complexes of ligand isomers), and stereo 
(such as geometrical, optical and conformational) isomers. More sophisticated induced 
geometrical,
1
 mer/fac,
2,3
 electronic,
4
 topological
5–7
 isomers or rotamers,
8–10
 as well as the 
controversial bond-stretch or distortion isomerism
11–14
 are also frequently discussed in the 
literature. The isomers possess altered physico-chemical properties that affect their reactivity 
and structure. The microenvironment around the metal ion affects the catalytic activity and 
selectivity of metalloenzymes or their small molecular model compounds. It determines their 
ability to recognize substrates, provide reactive sites by trans activation, electrostatically 
activate the substrate, generate nucleophile agents in hydrolytic reactions, or stabilize either 
the transition state or the products.
15–26
 The binding mode of metal ions greatly influences the 
conformation of ligands
27,28
 and vice versa. The change in protein structure induced by metal 
binding may lead to functional
29–35
 or pathogenic
36–44
 complexes. The recognition of the 
importance of coordination isomers opened new era in metallopharmaceutical design.
45,46
 
Drug delivery,
47
 bioprocessing,
48–50
 activity,
51–53
 selectivity
26,54
 and resistance
55–59
 can be 
optimized by selecting the isomeric drug or prodrug with the best properties.  
All metal complexes formed with multidentate ligands may exhibit linkage isomers.
60–
63
 By means of the “two-dimensional” approach to electron paramagnetic resonance (EPR) 
evaluation,
64
we have previously suggested the presence of linkage isomers in a number of 
copper(II) complex systems.
65–69
 This method defines EPR intensity as a function of the 
magnetic field, pH and the concentration of the metal complex. It furnishes the pertinent 
formation constants in the mass-balance equations together with the individual EPR 
parameters for all species simultaneously. Linkage isomers have also been studied by UV-Vis 
absorption,
62,70
 circular dichroism (CD)
71–73
 nuclear magnetic resonance (NMR)
74
 
spectroscopic investigations or applying multiple methods.
75
 These isomers of kinetically 
labile metal complexes cannot be studied separately. The spectrum decomposition to obtain 
individual thermodynamic and spectral data is practically impossible due to the intrinsic 
limitation by the constant concentration ratios of the microspecies during the pH-dependent 
series of measurements. The most commonly applied method to explore such systems is the 
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traditional way of selecting appropriate derivatives (mutants) to obtain basis limiting 
parameters for one or more isomers.  
On the other hand, the ratio of the isomeric species can be varied by e.g. the change of 
temperature
76–78
 or photoirradiation.
79–81
 The conformational changes of the heat shock 
proteins exemplify such temperature dependent isomeric switches with a biological 
significance.
82,83
 There is, however, still no comprehensive study on solution microequilibria 
of labile coordination linkage isomers proving their presence by temperature-dependent 
multiple methods.  
As a simple case we selected the His-Gly:Cu(II) = 1:1 system, where the predominant 
[CuL]
+
 complex at pH ~ 5.0 was suggested to exhibit two protonation isomers: {NH2,Nim} 
histamine-type (isomer h) and {NH2,N
–
,COO
–
} peptide-type (isomer p) complexes 
(Figure 1).
84
 In this work we made an attempt to directly distinguish these two complex 
isomers by temperature dependent series of measurements. Their thermodynamic and spectral 
properties were determined by EPR, conventional and synchrotron radiation (SR)CD 
spectroscopy and differential scanning calorimetry (DSC) in the systems containing 
copper(II) and His-Gly or His-Ala dipeptides. 
 
Figure 1 near here 
 
Experimental 
 
Materials.  
 
Sodium and copper(II) perchlorate were from Fluka and Reachim. The latter solution was 
standardized complexometrically. pH-metric titrations were performed by NaOH (Fluka) 
standard solution. The dipeptides were Sigma-Aldrich products. All the materials were used 
without further purification.  
 
pH-metric Measurements.  
 
The protonation and coordination equilibria were investigated by potentiometric titrations in 
aqueous solution (I = 0.1 M NaClO4, T = 298.2 ± 0.1 K and 328.2 ± 0.1 K) under argon 
atmosphere, using an automatic titration set including a PC controlled Dosimat 665 
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(Metrohm) autoburette and an Orion 710A precision digital pH-meter. The Metrohm Micro 
pH glass electrode (125 mm) was calibrated in aqueous solution via the modified Nernst 
equation:  
 
     
 
H
KJ
HJHKEE WOHHlog0 , 
 
where JH and JOH are fitted parameters in acidic and alkaline media, respectively for taking 
into account the deviations from the Nernst equation due to the liquid junction potential and 
either the acidic or the alkaline errors of the glass electrode,
85
 pKw = 13.75 is the negative 
logarithm of the autoprotolysis constant of water at 298.2 K,
86
 while the corresponding value 
at 328.2 K is 13.10.
87
 The parameters were calculated by the non-linear least squares method. 
The complex formation was characterized by the general equilibrium process: 
 
 
+-+2 rH+qL+pCu
 
+r)+q-(2p
rqp HLCu
+r)+q-(2p
rqp HLCu

, 
where L
–
 denotes the non-protonated ligand molecule. The corresponding formation constants 
(β(CupLqHr
(2p-q+r)+
) ≡ βpqr) were calculated using the PSEQUAD computer program.
88
 The 
protonation constants were determined from three independent titrations (70–80 data points 
per titration) with the peptide concentration of (1.0–3.0)·10–3 M. The complex formation 
constants were evaluated from three independent titrations (50–90 data points per titration) in 
case of copper(II) containing systems, respectively. The applied ratio of the ligands and metal 
ions was 1:1 with the metal ion concentration of (1.0–3.0)·10–3 M at the beginning of the 
titrations. The temperature range for the pH-metric titrations did not fully cover the range 
used for the EPR or CD experiments, 283.2–328.2 K for the former and 283.2–333.2 K for 
the latter. However, given the minimal change observed for the species distribution in the pH-
potentiometric titrations over the 298.2–328.2 K range (Figure S1.) it is safe to assume that 
there would be no significant change in the unexamined region. 
 
Continuous Wave-EPR Measurements.  
 
EPR spectra were measured with a Bruker EleXsys X-band spectrometer (microwave 
frequency 9.81 GHz, microwave power 10 mW, modulation amplitude 5 G, modulation 
frequency 100 kHz). The [CuL]
+
 complex of His-Gly and for comparison the [CuLH–1] 
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complex of Gly-Gly were obtained as major species in equimolar aqueous solutions of the 
components at 5 mM copper(II) and ligand concentration, the pH of which were adjusted to 
5.05 and 7.12, respectively (I = 0.1 M NaClO4). 100 l solution of each complex was 
transferred to a quartz EPR tube and the spectra were recorded between 283.2–328.2 K in 
steps of 5.0 K and at 77K, respectively. The temperature was adjusted by a liquid nitrogen 
based temperature controller system with an accuracy of ±0.1 K.  
 
Circular Dichroism Measurements. 
 
The Vis-CD spectra were recorded on a Jasco J-815 spectropolarimeter in the wavelength 
interval from 300 to 800 nm with 0.5 nm increments in a cell with 1 cm optical path length. 
The synchrotron radiation CD (SRCD) spectra of the free ligand and the metal complexes 
were recorded at the SRCD facility at the UV1 beamline
89
 on the storage ring ASTRID at the 
Institute for Storage Ring Facilities (ISA), University of Aarhus, Denmark. The light passed 
from the synchrotron through a CaF2 window into a CD instrument purged constantly with 
nitrogen. In the instrument an initial linear polarization is converted into alternating circularly 
polarized light with a CaF2 photo-elastic modulator (PEM, model I/CF50, Hinds, USA) 
operating at 50 kHz. The signal is detected with a photo-multiplier tube (PMT, 9402B, 
Electron Tubes, UK) using a lock-in amplifier. All spectra were recorded with 1 nm steps and 
a dwell time of 2s per step, using 0.1 mm quartz cells (SUPRASIL, Hellma GmbH, 
Germany). The spectra were recorded in the wavelength range of 170–330 nm. Camphor-
sulfonic acid served as a calibration material for the instruments. The substances were 
dissolved in distilled water and the pH was adjusted by HClO4 and NaOH solutions, for final 
metal ion and peptide concentration of ~5.0·10–3 M (I = 0.1 M NaClO4). The temperature was 
controlled by a built in Peltier unit. From raw spectra the water baseline was subtracted. 
 
Microcalorimetric Measurements.  
 
The calorimetric data were recorded on a Mettler-Toledo 822
e
 differential scanning 
calorimeter. Known quantities of the samples (~10 l) were put in the sample holder (~120 l 
medium pressure stein steel crucibles sealed with O-ring). The same amount of reference 
material was prepared in the same way. The difference of the amount of the heat was recorded 
(i.e. DSC scanning) as the function of the temperature in the range of 303.2–373.2 K with the 
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heating rate of 1.0 K/min. In the samples the concentrations of Cu(ClO4)2 and NaClO4 were 
0.01958 M and 0.1990 M, respectively, while the concentration of the His-Ala was 
0.02283 M. The reference samples contained only NaClO4 with the concentrations of 
0.2186 M or 0.1990 M. 
 
Data evaluation.  
 
The series of temperature dependent EPR spectra were simulated by the “two-dimensional” 
simulation program EPRTEMP.
90
 The program fits the isotropic EPR parameters of the 
components derived for 273.2 K (g0, A0 copper hyperfine coupling, aN nitrogen 
superhyperfine couplings) and the relaxation parameters  which define the linewidths 
in the equation  = +MI+MI
2
, where MI denotes the magnetic quantum number of 
copper nucleus. Since natural copper(II)chloride was used for the measurements, the 
calculated spectra were composed from the spectra of 
63
Cu and 
65
Cu by taking into account 
the ratio of hyperfine couplings according to the magnetic moments, the respective 
components were weighted by their natural abundances. The copper (referring to 
63
Cu) and 
nitrogen hyperfine couplings and relaxation parameters are given in field dimensions (gauss 
[G] = 10
-4
 T). The EPR parameters at a given temperature Q(T) can be calculated by a power 
expansion containing no more than four terms:  
 



3
0
0 )()(
n
n
n TTQTQ , 
where, T0 = 273.2 K, Q0 is the value at 273.2 K and Qn, (n = 1–3) coefficients can be fitted to 
describe the temperature dependence of Q(T). The thermodynamic parameters S and H 
were also fitted. The details of the fitting used for the investigated systems are described in 
the EPR Measurements section. 
For each spectrum, the noise-corrected regression parameter (Rj for the jth spectrum) 
is derived from the average square deviation (SQD) between the experimental and the 
calculated intensities. For the series of spectra, the fit is characterized by the overall 
regression coefficient R, calculated from the overall average SQD. The R value was 0.9965 
for the series of His-Gly and 0.9970 for the Gly-Gly temperature dependent EPR spectra. The 
details of the statistical analysis were published previously.
64,67,90
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The isomer ratios were calculated by the van’t Hoff relationship: 
RT
H
R
S
K



ln . In 
the equation, K is the isomerization stability coefficient at the temperature given, i.e., K 
equals to the ratio of the concentrations of histamine and the peptide type complex species. 
H and S are the reaction enthalpy and entropy for the formation of the histamine-type 
complex, respectively: 
isomer p isomer h . 
The same van’t Hoff relationship, combined with the mass-balance equations was 
applied for the evaluation of the CD, SRCD and calorimetric data. The Zita program package 
was applied for the latter calculations.
91
 
Matrix rank analysis was performed by the MRA program.
92
 
 
Results and discussion 
 
pH-Metric Titrations.  
 
In principle, the shift in microscopic equilibria between the coordination isomers can be 
monitored by temperature dependent spectroscopic measurements. The calculation of the 
individual spectra of the expected isomers from these data is only straightforward, if the 
distribution of the macrospecies is essentially unaffected during these experiments. This was 
verified by pH-potentiometric titrations of equimolar copper(II) – His-Gly system at 298.2 
and 328.2 K temperatures. The evaluation of the titration curves demonstrated that the [CuL]
+
 
complex was dominant at pH ~ 5.0 at both temperatures (Figure S1).  
 
EPR Measurements.  
 
The chemical exchange between the isomeric species is slow on the EPR time-scale thus, the 
EPR spectra of microspecies can be fitted by the superimposition of isotropic spectra of the 
respective species. The averaged EPR spectroscopic parameters (g0, A0, copper hyperfine 
coupling and  relaxation parameters) can be used to describe the individual spectrum at a 
certain temperature. The temperature dependence of these parameters can be taken into 
account by a power expansion (see Data evaluation section). A reference spectral series were 
first measured to determine the minimum required number of the coefficients necessary for 
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the description of the temperature-dependent EPR spectra. The [CuLH–1] complex of Gly-Gly 
dipeptide was selected with {NH2,N
–
,COO
–
} peptide type coordination being the predominant 
species at pH ~ 7.
67
 This type of coordination is expected for the isomer p of the His-Gly 
[CuL]
+
 complex, too. Simulations and parameter fitting procedures revealed that the linear 
dependence of g0, A0 and  parameters with fixed values for the nitrogen superhyperfine 
couplings and relaxation parameter was sufficient for the description of the temperature 
dependent spectra (Figure S2). The calculated parameters are shown in Table 1.  
 
The linear temperature dependence of the above parameters were taken into account in the 
simulation of the superimposed EPR spectra for both components of His-Gly [CuL]
+
 
complex. Our temperature-dependent pH-potentiometric titrations showed that the [CuL]
+
 
complex was dominant at pH ~ 5.0, with only few percent of the [CuLH]
2+ 
and [Cu2L2H–2] 
complexes present. The EPR spectrum of [CuLH]
2+
 is very similar to the spectrum of the 
histamine-type [CuL]
+
 isomer, and the spectrum of the dimer [Cu2L2H–2] complex is a broad 
singlet, therefore, the new well resolved component with EPR parameters close to those of 
Gly-Gly [CuLH–1] could only be considered as a peptide-type linkage isomer of [CuL]
+
. The 
temperature dependent spectral series were then fitted by taking into account the two 
microspecies of the [CuL]
+
 complex (Table 1 and Figure 2). The coordination modes in Gly-
Gly [CuLH–1] and His-Gly [CuL]
+
 peptide-type complexes are the same, but slight differences 
in their EPR parameters were observed owing to the presence of the His side-chain in the 
latter complex, which modifies the electron density at the donor atoms of the ligand and the 
rotation correlation time, as well. By this approach we could obtain more reliable parameters 
for the minor species as compared to our earlier results (g0 = 2.1323, A0 = 54.5 G, 
aN1 = 14.0 G and aN2 = 13.0 G).
84
 The EPR parameters of the predominant histamine-type 
isomer are in good accordance with previously determined data,
84
 as well as, with those 
obtained for histamine [CuL]
2+
 complex (g0 = 2.1436, A0 = 63.4 G, aN1 = 12.7 G and 
aN2 = 11.4 G)
93
 supporting the hypothesized type of coordination in this isomer. This model 
resulted in a good agreement between the measured and simulated EPR spectra (Figure 2c).  
 
Figure 2 near here 
 
At first sight, the temperature dependence of the parameters provided surprising results. The 
higher the temperature the lower bond strength and thus, the increase of the g0 and decrease of 
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the A0 values is expected. Indeed, for g0 this was the case for the two His-Gly complex 
isomers but not for the [CuLH–1] complex of Gly-Gly. We may resolve this apparent 
contradiction by the analysis of the equation 
E
n
gg e


 2
 (where  is a molecular orbital 
coefficient, n a quantum mechanical coefficient,  is the spin-orbit coupling and E is the 
energy difference between the ground state and the excited states), g0 depends on the ratio of 
the spin-orbit coupling and the separation of the energy levels. We may assume that at 
elevated temperature the decrease of the spin-orbit coupling, as the consequence of more 
diffuse molecular orbitals, can exceed the effect of the decrease in the separation of energy 
levels. Accordingly, the g0 value may decrease with the increasing temperature. The 
temperature dependence of the A0 value is in addition, connected with the Fermi contact term 
related to the 3d-4s orbital mixing.
94
 For the “histamine-type” isomer of Hys-Gly complex A0 
decreases but for the “peptide-type” species A0 increases upon increase of the temperature. 
We assume that a slightly different symmetry distortion of the molecular orbitals may 
influence the 3d-4s orbital mixing in different manner. 
From the temperature dependence of the isomer ratio (see Table S1 and Figure 3) the 
standard enthalpy and entropy changes of the isomer equilibrium could be determined as 
H = –21.4 kJ/mol and S = –62 J/mol/K with the standard errors of 0.4 kJ/mol and 
1 J/mol/K, respectively. Deviations could not be correctly calculated due to the unknown 
correlation values. The thermodynamic data show that the higher temperature is favourable 
for peptide-amide deprotonation, while the side-chain coordination becomes predominant at 
low temperature. 
 
Figure 3 near here 
 
The EPR spectrum of the His-Gly [CuL]
+
 complex recorded in frozen solution at 77 K 
showed characteristic features of a dimer copper(II) complex formation (Figure S3), but 
distinct from that of the [Cu2L2H–2] complex.
84
 This indicates that the macroscopic 
equilibrium shifts under such condition, and the anisotropic EPR spectrum does not provide 
further insight into the equilibrium of the histamine- and peptide-type linkage isomers of the 
[CuL]
+
 complex.  
 
CD Measurements in the Wavelength Range of the Visible Light.  
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Our initial CD measurements in equimolar copper(II) His-Gly system yielded too small 
deviation between the spectra recorded at 293.2 and 333.2 K under conditions of the isomer 
formation (Figure S4). The reason for this is that the C-terminal Gly residue of the ligand is 
optically inactive thus, the transmission of the ligand optical activity to the copper(II) 
chromophore is ineffective.
95,96
 As the quantitative evaluation of these spectra would be 
ambiguous, we applied the His-Ala dipeptide with a chiral amino acid at its C-terminus in 
further CD investigations. The methyl side chain of alanine does not influence the 
coordination properties towards copper(II)ion. Thus, the equilibrium constants, i.e. the species 
distribution are essentially the same as in the copper(II)–His-Gly system.97–99 The CD pattern 
of this system changed substantially within the 283.2–333.2 K temperature range (Figure 4a). 
It can also be seen that the spectrum recorded at low temperature is alike those of the 
copper(II) complexes with histamine-type, i.e. {NH2,Nim} coordination
96
 in agreement with 
the EPR measurements. At the same time, on increase of the temperature the negative band 
around 650 nm becomes more pronounced. This band is characteristic for the copper(II) 
complexes with peptide-type {NH2,N
–
,COO
–
} coordination.
95
 Thus, the ratio of the two 
isomers clearly changes: the complexation of the chelating backbone atoms including the 
deprotonated amide nitrogen is favoured at elevated temperature against the side-chain type 
coordination.  
The Gly-Leu dipeptide containing a chiral amino acid with non-coordinating side-
chain at the C-terminus was selected for comparison. The CD spectrum of its copper(II) 
complex was recorded at pH 7.0, where the {NH2,N
–
,COO
–
} coordinated peptide-type 
[CuLH–1] species dominates in the solution.
97,99
 The temperature change in the same range as 
for the His-Ala complex did not significantly affect the CD pattern (Figure 4b). This suggests 
that the temperature change, and in parallel the eventual shift of the conformational 
population of the bound ligand molecule had no or minor influence on the Cotton effect 
obtained in the wavelength range that is characteristic for d-d transitions. This is also reflected 
by the success of the matrix rank analysis of the temperature dependent CD spectral series of 
the copper(II)–His-Ala system. The MRA program92 was able to fit the data by hypothesizing 
the presence of only two species in the solution (Figure S5).  
 
Figure 4 near here 
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Together with the pH metric results on the validity of macrospeciation, these 
observations support that the change of the CD pattern in copper(II)–His-Ala system is indeed 
due to the shift of the microequilibria upon the change of the temperature. Thus, the CD data 
obtained in the copper(II)–His-Ala system as a function of the temperature were used to fit 
the thermodynamic data by non-linear parameter estimation. For the fitting procedure, the 
previously mentioned van’t Hoff equation, the Beer-Lambert law and the mass-balance 
equations were applied. Fitting the CD data for the isomerization of the [CuL]
+
 complex 
resulted in a good agreement between the measured and simulated spectra (Figure S6). 
Together with H and S, the individual molar ellipticities of the two isomers were also 
obtained (Figure 5).  
 
Figure 5 near here 
 
The molar spectrum of one of the isomers corresponds well to those published 
previously for monohistamine-type copper(II) complexes (λmax = 746-752 nm, ∆ = 0.09–0.11 
M
–1
cm
–1
).
96
 The spectrum of the other isomer resembles the [CuLH–1] complexes of Cu(II) 
Gly-Ala dipeptide (λmin = 650 nm, ∆ = –0.35 M
–1
cm
–1
)
100
 and the Ala-rich tetrapeptides (λmin 
= 685 nm, –∆ = 0.24–0.32 M–1cm–1)101 with {NH2,N
–
,CO} type of coordination, as well as 
that of the Gly-Leu complex, although with smaller intensity. Thus, the calculated spectra can 
be assigned to the “histamine-type” and “peptide-type” isomers of the [CuL]+ complex of His-
Ala, respectively. The calculated H and S values for the formation of isomer h were (–
22.93.5) kJ/mol and (–6511) J/mol/K, respectively in accordance with the EPR result for 
the copper(II)–His-Gly system. The relatively high deviation values arose from the fact that 
thermodynamic parameters cannot inherently be determined more accurately. The obvious 
explanation of this statement is demonstrated by Figure 6.  
 
Figure 6 near here 
 
The temperature range of the detectable ellipticity change is about 300 K. Accurate 
determination of the influencing parameters would require the investigation of this whole 
temperature range to get sufficient information about the shape of the (T) curves. However, 
only a small part of this range is experimentally achievable in aqueous solutions, leading to 
13 
 
large correlations between the parameters. Nevertheless, the above values are in agreement 
with those calculated from the EPR data. 
 
SRCD Measurements.  
 
Previous SRCD measurements showed that solutions of small peptides show characteristic 
and pH sensitive CD pattern in the far UV wavelength region.
102
 This observation can be 
explained in terms of the unique peptide conformation population in each of different 
protonation state. The metal ion coordination also greatly affects the spectra through the 
emerging charge transfer transitions and by changing the ligand conformation population. 
Therefore, we expected that the change in the coordination type in the isomeric equilibrium 
will also have a significant effect on the spectra, and carried out temperature dependent SRCD 
measurements with His-Gly, His-Ala and Gly-Leu as well as with their copper(II)-complexes 
in the 283.2–333.2 K range, at pH 5.07 for the first two dipeptides and at 7.00 for the latter, 
respectively. The series of the SRCD spectra for His-Gly and its [CuL]
+
 complex are depicted 
in Figure 7, and those measured for His-Ala and Gly-Leu are included in the electronic 
supplementary material (Figure S7).  
 
Figure 7 near here 
 
While the spectra were recorded in the 170–330 nm wavelength range, the plots were reduced 
to 175–330 nm range, as below 175 nm the absorption of the distilled water already resulted 
in maximum high tension voltage at the photomultiplier unit, causing the data to be unreliable 
(Figure S8). The minimum wavelength limit of the maximum high tension was typically 
between 176–178 nm (Figure S9) and only the CD data obtained above the limiting values 
were taken into account in the evaluation process. 
Generally, the spectra of the free ligands differ from those of the metal containing 
systems at all temperatures examined. While only slight variation of the SRCD spectra can be 
observed within the series recorded for the His-Gly or His-Ala free ligands, the spectra of 
their [CuL]
+
 complexes exhibit more pronounced temperature dependent changes. On the 
other hand, the extent of the spectral variation upon temperature change is similar in case of 
the free form and the copper(II)-complex of Gly-Leu peptide. As no linkage isomers of this 
peptide can form in its [CuLH–1] complex, the modest temperature-dependent spectral 
variations reflect only the increased flexibility of the molecule at elevated temperatures. 
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Taken together, this indicates that the shift of coordination isomer microequilibrium has 
major contribution to the conformational changes of the ligands in copper(II)–His-Gly or His-
Ala complexes.  
The results of the MRA calculations on the temperature dependent SRCD spectral 
series obtained for the metal complexes is shown in Table S2. It can clearly be seen that the 
first two diagonal elements are significant in comparison with their standard deviation values 
for the His-Gly and His-Ala complexes, while only there is only one diagonal element of this 
kind for the copper(II)–Gly-Leu system. This again supports the presence of the isomeric 
species in the former complexes. The detailed analysis of the residual curves (Figure S10) 
revealed that none of the above systems can be perfectly interpreted with the MRA program, 
indicating that there is a continuous change in the shape of the spectra of individual species as 
the function of the temperature. The chiral effect leading to the observed SRCD spectra stems 
from the sum of the inherent configurational chirality and the contribution of the linkage and 
ligand conformational isomers. All of these may simultaneously change with the temperature, 
increasing the complexity of the data analysis. No common algorithm is available yet to 
handle the SRCD data by appropriate quantum and physico-chemical approach, similar to that 
applied above for the EPR spectra. The development of such a program would, however, be 
of great importance, as it could provide additional information on the ligand conformation in 
its complexed form in aqueous solutions. 
 
Microcalorimetric Experiments.  
 
The isomerization enthalpy was calculated from the differential scanning calorimetric data by 
the combination of the van't Hoff equation and the basic energy conservation equations. The 
repeated experiments led to the –H = (19–27) kJ/mol range for the formation of the h isomer 
from p. This is in agreement with the values determined by spectroscopic methods, although, 
this range seems wide as it was the case for the CD experiments, too. Limited data are 
available in the literature for isomeric equilibria. An example is the cis to trans isomer 
conversion of N-phosphoryl thioureas, where similar –H = (13–15) kJ/mol values were 
obtained.
103
  
The negative value in our system reveals that the conversion of the {NH2, N
–
, COO
–
} 
peptide-type copper(II) complex to its {NH2, Nim} histamine-type linkage isomer is an 
exothermic process. This can be explained by the fact that the protonation of the backbone 
15 
 
amide group is favoured at pH ~ 5, taken that its basicity is much higher compared to the 
imidazole side-chain nitrogen. Accordingly, the formation of peptide-type coordination mode 
in the reaction of Gly-Gly with copper(II) was shown to be slightly endothermic (1.6–
2.8 kJ/mol).
103
 In addition, the positive mesomeric effect of the imidazole ring increases the 
electron density on the nitrogen donor group, strengthening the copper(II)–Nim bond, as 
demonstrated by the negative standard reaction enthalpy related to the formation of 
copper(II)–histamine [CuL]2+ complex (–54.3 kJ/mol).104  
 
Conclusions 
 
Our analysis of temperature dependent spectroscopic data showed a direct evidence for the 
existence of the peptide- and histamine-type linkage-isomers of His-Gly and His-Ala [CuL]
+
 
complexes, followed by their characterization – without applying close derivatives of the 
ligands. According to the results of the EPR and CD measurement, the histamine-type 
complex (~80 %) is predominant at room temperature but its amount decreased with the 
increase of the temperature, and the percentage of the peptide-type complex could reach 40 % 
at 328.2 K. The thermodynamic parameters (i.e. the standard enthalpy and entropy changes) 
of the isomerisation process – determined by both calorimetric and spectroscopic methods – 
revealed essentially the same numerical values with similar uncertainty. Based on these 
results, we can discuss the behaviour of the isomers. The strong binding of the imidazole 
nitrogen donor group to the copper(II) ion lowers the enthalpy of the histamine-type complex. 
On the other hand, the tridentate coordination in case of the peptide-type isomer results in the 
higher number of freely moving atoms in the uncoordinated histidine side-chain, and the 
release of an additional water molecule from the coordination sphere of the copper(II)ion,  
leading to entropy increase. Thus, the conversion of peptide-type isomer of [CuL]
+
 into 
histamine-type linkage isomer seems to be promoted by the negative standard reaction 
enthalphy at low temperatures, but the opposite reaction is favourable at high temperatures 
due to the entropy increase. 
The experimental methods for the detection, structural and thermodynamic 
characterization of microspecies in labile metal complex systems has to be carefully selected. 
EPR for paramagnetic complexes, NMR for diamagnetic ones, UV-Vis for those with a 
sensitive chromophore and CD for those possessing chirality is an obvious choice. In specific 
systems, the monocomplexes formed by each of the multiple binding sites offering the same 
donor atom set (e.g. {3×N–,NIm} for copper(II) in certain proteins) can be considered as 
16 
 
linkage isomers.
71–73,75
 In such cases CD spectroscopy can perform better than EPR because it 
is sensitive to the differences in the chiral environment provided by the amino acid side 
chains. Another advantage of the CD spectroscopic measurements carried out in the 
wavelength range of the d-d transitions is that the spectra of single species (isomers) are not 
sensitive to the temperature change, allowing for a simple evaluation of the data. The CD 
measurements in the UV range could be more generally performed for all complexes 
containing chiral ligands (most of the bioligands). By developing a common algorithm to 
parametrize and fit these spectra, not only the presence of the isomers, but the conformation 
of the complexed ligands could be monitored using this method, requiring minimal 
stoichiometric amounts of substances. Such experiments would complement NMR e.g. for the 
paramagnetic metal complexes. 
With the forewarning in mind that the widest accessible temperature range in aqueous 
solutions is an inherent limitation of the experiments, our study shed light on the potential of 
temperature-dependent measurements by the properly chosen spectroscopic methods to 
directly characterize linkage-isomers of kinetically labile metal complexes.  
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Table 1. Isotropic EPR parameters of Gly-Gly [CuLH–1] and two isomers of His-Gly [CuL]
+
 
complexes. The temperature dependence of parameters was characterized by the 
Q(T) = Q0+Q1(T–273.2) linear equation, where T is the temperature in K units and Q0 is the 
parameter value at 273.2 K. The confidence intervals of the last digit (3) at a significance 
level of 99.7% are given in parentheses.  
 
  L = GG L = HG 
      isomer p isomer h 
  Q0 Q1 /deg Q0 Q1 /deg Q0 Q1 /deg 
g0 2.1202(1) –5.1(5)·10
–4
 2.115(1) 1.3(5)·10–4 2.1437(5) 6.8(1)·10–5 
A0 /G 67.2(2) –0.007(6) 63(1) 0.04(3) 60.4(3) –0.053(3) 
aN,1 /G 14.1(2) - 14(1) - 12.5(6) - 
aN,2 /G 11.7(2) - 14(1) - 11.5(6) - 
 /G 14.7(2) 0.153(1) 21(2) 0.24(8) 34.1(9) –0.08(2) 
 /G –6.7(1) 0.072(2) –10(1) 0.06(4) –16.6(4) 0.15(1) 
 /G 0.8(2) - 2(1) - 1.9(2) - 
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Figure legends 
 
Figure 1. Peptide-type (left) and histamine-type (right) coordination in the linkage isomers of 
[CuL]
+
 complex of His-Gly (L) 
 
Figure 2. Temperature dependent EPR spectra calculated for (a) peptide- and (b) histamine-
type isomer of His-Gly [CuL]
+
 complex at pH = 5.05. Spectra were calculated at 283.2 K 
(blue), at 328.2 K (red) and in between (black). (c) Comparison of measured (black) and 
simulated (red) EPR spectra. A vertical line helps to follow the apperance of the sharpest line 
of the peptide-type isomer. 
 
Figure 3. The temperature dependence of the ratio of the histamine and peptide type isomers 
of [CuL]
+
 complex of His-Gly, according to the calculations based on the change of the EPR 
spectra. 
 
Figure 4. Temperature dependent CD spectra recorded in the 300-800 nm wavelength range 
for equimolar systems of copper(II) and (a) His-Ala with [CuL]
+
 complex dominating at 
pH = 5.00, (b) Gly-Leu with the peptide-type [CuLH–1] complex dominating at pH = 7.00 in 
the equilibrium system. The copper(II) ion concentration was ~5.0·10–3 M in a cuvette with 
1 cm optical path length.  
 
Figure 5. The calculated molar CD spectra for the [CuL]
+
 isomers of His-Ala. The spectrum 
of the histamine-type isomer is in blue, while that of the peptide-type isomer is in red. 
 
Figure 6. The measured (filled circles) and the calculated (solid lines) ellipticity values of the 
[CuL]
+
 complex of His-Ala as the function of the temperature at four different wavelengths. 
The copper(II) ion concentration was ~5.0·10–3 M in a cuvette with 1 cm optical path length. 
 
Figure 7. Temperature dependent SRCD spectra recorded (a) for the His-Gly dipeptide and 
(b) for its [CuL]
+
 complex at pH = 5.00 in the equilibrium system. The optical path length 
was 0.1 mm.  
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